Keywords: shares, take, tumble, glaxo, wellcome, abandons, double-digit
Shares take a tumble as Glaxo Wellcome abandons double-digit growth promise
Article | 30 July 1999
Although it reported reasonable rises in sales and pretax profits forfirst-half 1999 (Marketletter August 2), Glaxo Wellcome saw its shares take a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
